The global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast period, reflecting the expanding role of mRNA ...
From global vaccines to personalized cancer therapies, mRNA is being considered across several clinical applications, which ultimately creates varying requirements in terms of production scale and ...
A 3-year research program, funded by the FDA, aims to design the first continuous mRNA-manufacturing platform. Faculty at the Massachusetts Institute of Technology (MIT; MA, USA) will be leading a ...
CAMBRIDGE, MA -- A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U ...
SINGAPORE – The Nucleic Acid Therapeutics Initiative (NATi), a national platform hosted by the Agency for Science, Technology and Research (A*STAR), officially launched the non-GMP NATi mRNA ...
- Agreement Seeks to Leverage Linea IVT Platform to Enable Kudo Bio to Offer a Differentiated mRNA Manufacturing Capability with Mitigated dsRNA and Reduced Turnaround Times - STONY BROOK, NY and ...